Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 14 15 16 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Roche. (11/16/17). "Press Release: FDA Approves Roche’s Hemlibra (emicizumab-kxwh) for Haemophilia A with Inhibitors". Basel. 2017-11-16
Boehringer Ingelheim. (11/15/17). "Press Release: Key Sub-analyses of RE-DUAL PCI Showed Large Reductions in the Incidence of Bleeding Complications if Pradaxa (dabigatran etexilate) Dual Therapy Was Used Instead of Warfarin Triple Therapy". Ingelheim. 2017-11-15
Arvinas, LLC. (11/15/17). "Press Release: Arvinas Expands Strategic License Agreement with Genentech". New Haven, CT. 2017-11-15
Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. 2017-11-15
Arsanis, Inc.. (11/15/17). "Press Release: Arsanis Announces Pricing of Initial Public Offering". Waltham, MA & Vienna. 2017-11-15
High-Tech Gründerfonds Management GmbH. (11/14/17). "Press Release: Scipio Bioscience Announces Its Seed Funding". 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: Jardiance Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Peripheral Artery Disease". Ingelheim & Indianapolis, IN. 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: New RE-VERSE AD Analyses Provide Additional Insights on Impact of Praxbind (idarucizumab) in Pradaxa (dabigatran etexilate) Patients with Gastrointestinal Bleeding or Needing Emergency Surgery". Ingelheim 2017-11-14
Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT. 2017-11-14
Qiagen N.V.. (11/14/17). "Press Release: Qiagen’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology". Hilden & Germantown, MD. 2017-11-14
Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs". Zug, Cambridge, MA, Tübingen & Boston, MA. 2017-11-13
Boehringer Ingelheim. (11/13/17). "Press Release: Cyltezo, Adalimumab Biosimilar from Boehringer Ingelheim, Approved in Europe for the Treatment of Multiple Chronic Inflammatory Diseases". Ingelheim. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer". Zug & Cambridge, MA. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic [The information contained in this release is not appropriate for audiences in the USA and Canada]". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Introduces Stericup Quick Release System for Improved Cell Culture Filtration". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Receives FDA Approval for New Gonal-f Prefilled Pen [Not intended for U.S. and UK based media]". Darmstadt. 2017-11-13
Royal Philips. (11/13/17). "Press Release: German Armed Forces to Use Customized Philips Lumify Ultrasound for Its Emergency and Rescue Operations". Amsterdam. 2017-11-13
Qiagen N.V.. (11/13/17). "Press Release: Qiagen Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony". Hilden & Germantown, MD. 2017-11-13
EBD Group. (11/13/17). "Press Release: BIO-Europe 2017 Brings over 4,000 Biotech and Pharma Execs to Berlin and Breaks All Previous Partnering Records". Carlsbad, CA & Berlin. 2017-11-13
GNA Biosolutions GmbH. (11/13/17). "Press Release: GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica". Düsseldorf. 2017-11-13
Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg. 2017-11-12
Boehringer Ingelheim. (11/10/17). "Press Release: Boehringer Ingelheim Presents New Data for Pradaxa and Its Specific Reversal Agent Praxbind at AHA Scientific Sessions 2017". Ingelheim. 2017-11-10
DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. 2017-11-09
Vetter Pharma International GmbH. (11/9/17). "Press Release: Vetter Expands Its Footprint in Asia Pacific Region. Company Establishes Its Presence in South Korea". Songdo & Ravensburg. 2017-11-09
Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. 2017-11-09
Neurimmune AG. (11/9/17). "Press Release: Neurimmune Announces Collaboration with Ono Pharmaceutical in Neurodegenerative Diseases Field". Schlieren. 2017-11-09
InflaRx N.V.. (11/8/17). "Press Release: InflaRx Announces Pricing of Initial Public Offering". Jena. 2017-11-08
Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London. 2017-11-08
Definiens AG. (11/8/17). "Press Release: Definiens Broadens Immuno-Oncology Service Offer. Predictive Multi-biomarkers for Accelerated Immuno-oncological Progress". Washington, D.C.. 2017-11-08
Evotec AG. (11/8/17). "Press Release: Evotec AG Announces First Nine-month 2017 Results and Corporate Update". Hamburg. 2017-11-08
CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA. 2017-11-08
Endress+Hauser AG. (11/8/17). "Press Release: Endress+Hauser Acquires Blue Ocean Nova. Intelligent Inline Spectrometers Strengthen the Process Analytical Instrumentation Portfolio". 2017-11-08
G1 Therapeutics, Inc.. (11/8/17). "Press Release: G1 Therapeutics Makes Key Executive Appointments. Barclay Phillips Appointed Chief Financial Officer and Senior Vice President, Corporate Development". Research Triangle Park, NC. 2017-11-08
MorphoSys AG. (11/7/17). "Press Release: MorphoSys Announces Third Quarter 2017 Results". Planegg. 2017-11-07
Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon. 2017-11-07
Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. 2017-11-07
NousCom AG. (11/6/17). "Press Release: NousCom Raises €42 Million Series B Financing". Basel. 2017-11-06
Boehringer Ingelheim. (11/6/17). "Press Release: Efficacy and Safety Maintained in Patients Who Switched from Humira to Biosimilar Cyltezo". Ingelheim. 2017-11-06
Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon. 2017-11-06
Eurofins Scientific. (11/6/17). "Press Release: Eurofins Successfully Prices EUR 400m New Hybrid Bond". 2017-11-06
Evotec AG. (11/6/17). "Press Release: Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build »NEPLEX«". Hamburg. 2017-11-06
Qiagen N.V.. (11/6/17). "Press Release: Qiagen Reports Results for Third Quarter and First Nine Months of 2017". Venlo. 2017-11-06
Glycotope GmbH. (11/3/17). "Press Release: Celonic Acquires Glycotope’s Biomanufacturing Facility". Basel. 2017-11-03
Boehringer Ingelheim. (11/2/17). "Press Release: Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)". Ingelheim & Cambridge, MA. 2017-11-02
Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg. 2017-11-02
Bruker Corporation. (11/2/17). "Press Release: Bruker Reports Third Quarter 2017 Financial Results". Billerica, MA. 2017-11-02
Servier. (11/2/17). "Press Release: Servier Germany to Co-promote Novartis’ Blockbuster Entresto". 2017-11-02
Merck KGaA. (11/1/17). "Press Release: Merck and Samsung BioLogics to Extend Strategic Alliance". Darmstadt. 2017-11-01
Bruker Corporation. (11/1/17). "Press Release: Bruker Merger of Sweden Subsidiaries". Solna. 2017-11-01
Novartis AG. (10/30/17). "Press Release: Novartis to Present First of its Kind Evidence for Cosentyx on Potential to Maintain Mobility in Patients with AS and PsA". Basel. 2017-10-30
Novartis AG. (10/30/17). "Press Release: Novartis Announces the Planned Acquisition of Advanced Accelerator Applications to Strengthen Oncology Portfolio". Basel. 2017-10-30
CureVac AG. (10/30/17). "Press Release: CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics". Tübingen. 2017-10-30
MorphoSys AG. (10/30/17). "Press Release: Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer". Planegg. 2017-10-30
Euronext N.V.. (10/30/17). "Press Release: Theranexus Takes Its First Steps on Euronext Growth". Paris. 2017-10-30
Boehringer Ingelheim. (10/30/17). "Press Release: Boehringer Ingelheim Expands Collaboration with Sarah Cannon Research Institute to Investigate Novel Immuno-oncology Combination Therapy". Ingelheim & Nashville, TN. 2017-10-30
Glycotope GmbH. (10/30/17). "Press Release: Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing". Tokyo, Basking Ridge, NJ & Berlin. 2017-10-30
Kymera Therapeutics LLC. (10/30/17). "Press Release: Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies". Cambridge, MA. 2017-10-30
Qiagen N.V.. (10/30/17). "Press Release: Qiagen Accelerates Adoption of Molecular Testing for Life Sciences and Molecular Diagnostics Companies with Launch of Custom Solutions Business". Beverly, MA. 2017-10-30
Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. 2017-10-28
Novartis AG. (10/27/17). "Press Release: Sandoz Proposed Biosimilar Pegfilgrastim Accepted by EMA for Regulatory Review". Holzkirchen. 2017-10-27
Clariant. (10/27/17). "Press Release: Clariant and Huntsman Jointly Decided to Abandon Planned Merger of Equals". Muttenz. 2017-10-27
CureVac AG. (10/27/17). "Press Release: CureVac Initiates Phase I Clinical Trial of RNAdjuvant Candidate as Intratumoral Therapy for Solid Tumors". Tübingen & Boston, MA. 2017-10-27
4SC AG. (10/26/17). "Press Release: 4SC Provides Q3 and 9M 2017 Update". Planegg-Martinsried. 2017-10-26
Topas Therapeutics GmbH. (10/26/17). "Press Release: Topas Therapeutics Appoints Rupert Sandbrink, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer". Hamburg. 2017-10-26
Akampion. (10/26/17). "Press Release: Akampion Hosts Expert Panel at BIO-Europe 2017, Co-authors Scientific Article in Human Gene Therapy". 2017-10-26
Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]". 2017-10-26
Evotec AG. (10/26/17). "Press Release: Evotec and Tesaro Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents". Hamburg. 2017-10-26
InSphero AG. (10/26/17). "Press Release: InSphero and Charles River Announce PDX Partnership". Schlieren. 2017-10-26
Novartis AG. (10/25/17). "Press Release: Novartis Confirms Leadership in Multiple Sclerosis (MS) with Scientific Advancements and New Data presented at ECTRIMS". Basel. 2017-10-25
BioMed X GmbH. (10/25/17). "Press Release: BioMed X Announces Biomedical Research Collaboration with Janssen". Heidelberg. 2017-10-25
Thermo Fisher Scientific Inc.. (10/25/17). "Press Release: Thermo Fisher Scientific Reports Third Quarter 2017 Results". Waltham, MA. 2017-10-25
Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg. 2017-10-24
Idorsia Ltd.. (10/24/17). "Press Release: Idorsia Announces Financial Results as of 30 September 2017". Allschwil. 2017-10-24
AiCuris Anti-infective Cures GmbH. (10/24/17). "Press Release: AiCuris AIC649 Showed Potential for Functional Cure in Woodchuck Model for Chronic Hepatitis B". Wuppertal. 2017-10-24
Novartis AG. (10/24/17). "Press Release: Novartis Delivered Growth on Top and Bottom Line in All Divisions in Q3". Basel. 2017-10-24
Eurofins Scientific. (10/24/17). "Press Release: With 33% CAGR Annual Value Creation since Its IPO 20 Years Ago (over 296 Times Appreciation) a Study Finds that Eurofins Ranks First in Value Creation of All Stocks ÖListed in Europe since October 24, 1997 2017-10-24
Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Announces Agreement with the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis". South San Francisco, CA. 2017-10-24
Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues". South San Francisco, CA. 2017-10-24
Ionicon Analytik GmbH. (10/24/17). "Press Release: Ionicon Presents the New Charon Aerosol Inlet for PTR-TOFMS". Innsbruck. 2017-10-24
Merck KGaA. (10/24/17). "Press Release: Canadian Patent Office to Grant Merck's Patent Application for CRISPR Technology". Darmstadt. 2017-10-24
Qiagen N.V.. (10/24/17). "Press Release: Qiagen and ICMP Launch Next-generation DNA Testing Solutions for Identifying Missing Persons". The Hague. 2017-10-24
Ascenion GmbH. (10/23/17). "Press Release: Ascenion’s Portfolio Company SurgVision Acquired by Bracco Imaging. Making Cancer Surgery more Precise". Munich. 2017-10-23
Novartis AG. (10/23/17). "Press Release: Novartis Combination Adjuvant Therapy Tafinlar + Mekinist Receives FDA Breakthrough Therapy Designation for Stage III BRAF V600 mutation-positive melanoma patients". Basel. 2017-10-23
Curetis N.V.. (10/23/17). "Press Release: Curetis Initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge". Amsterdam & Holzgerlingen. 2017-10-23
CureVac AG. (10/23/17). "Press Release: Publication in npj Vaccines Demonstrates CureVac’s RNActive Vaccine Is Superior to Licensed Vaccines". Tübingen & Boston, MA. 2017-10-23
MorphoSys AG. (10/23/17). "Press Release: MorphoSys Receives FDA Breakthrough Therapy Designation for Its Antibody MOR208 in Relapsed/Refractory DLBCL". Planegg. 2017-10-23
ADC Therapeutics S.A.. (10/23/17). "Press Release: ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials". Lausanne. 2017-10-23
Thermo Fisher Scientific Inc.. (10/23/17). "Press Release: New Unrivalled Capabilities Take GC-MS to the Next Level of Performance. Enhancements to Thermo Scientific Orbitrap GC-MS Systems". Sunnyvale, CA. 2017-10-23
UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels. 2017-10-20
Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". 2017-10-20
ThromboGenics N.V.. (10/20/17). "Press Release: ThromboGenics Business Update – Q3 2017". Leuven. 2017-10-20
Heidelberg Pharma AG. (10/19/17). "Press Release: Wilex AG Successfully Completes Change of Name to Heidelberg Pharma AG". Ladenburg. 2017-10-19
High-Tech Gründerfonds Management GmbH. (10/19/17). "Press Release: Venture Capital. RWE Generation Invests in HTGF III". 2017-10-19
Apceth Biopharma GmbH. (10/19/17). "Press Release: DCPrime and Apceth Biopharma GmbH Announce Manufacturing Partnership". Leiden & Munich. 2017-10-19
Merck KGaA. (10/19/17). "Press Release: Merck Brings Customers Closer to Gene Therapy Product Commercialization". Darmstadt. 2017-10-19
Roche. (10/19/17). "Press Release: Roche Reports Strong Sales Growth in the First Nine Months of 2017". Basel. 2017-10-19
Qiagen N.V.. (10/19/17). "Press Release: Qiagen Announces High Accuracy of Bioinformatics Solutions in Women’s Health Genetic Screening". Orlando, FL, Germantown, MD & Hilden. 2017-10-19
Peak Scientific Instruments Ltd.. (10/19/17). "Press Release: Peak Scientific Expands Presence in Europe". 2017-10-19
CureVac AG. (10/18/17). "Press Release: Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines". Indianapolis, IN & Tübingen. 2017-10-18
next pagenext page 1 2 3 ... 14 15 16 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top